Cargando…
Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinoma
Background: Few overlaps between prognostic biomarkers are observed among different independently performed genomic studies of esophageal squamous cell carcinoma (ESCC). One of the reasons for this is the insufficient cohort size. How many cases are needed to prognostic genes analysis in ESCC? Metho...
Autores principales: | Kong, Linghong, Yang, Ming, Wan, Zhiyi, Wang, Lining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941191/ https://www.ncbi.nlm.nih.gov/pubmed/36825282 http://dx.doi.org/10.3389/pore.2023.1610909 |
Ejemplares similares
-
Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022) -
Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma
por: Zhang, Ning, et al.
Publicado: (2021) -
Associations of Porphyromonas gingivalis Infection and Low Beclin1 Expression With Clinicopathological Parameters and Survival of Esophageal Squamous Cell Carcinoma Patients
por: Guo, Yibo, et al.
Publicado: (2021) -
Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
por: Li, Hui, et al.
Publicado: (2023) -
Prognostic value of pretreatment Controlling Nutritional Status score in esophageal cancer: a meta-analysis
por: Lv, Jing, et al.
Publicado: (2023)